Spinocerebellar Ataxia With Axonal Neuropathy Type 2

Neurology·MeSH: Brachydactyly-Nystagmus-Cerebellar Ataxia

Prevalence

0.5 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinocerebellar Ataxia With Axonal Neuropathy Type 2?

There are 1 clinical trial targeting Spinocerebellar Ataxia With Axonal Neuropathy Type 2 tracked by BioSniper.

What is the prevalence of Spinocerebellar Ataxia With Axonal Neuropathy Type 2?

The estimated prevalence of Spinocerebellar Ataxia With Axonal Neuropathy Type 2 is approximately 0.5 per 100,000 population.

Deep-dive into Spinocerebellar Ataxia With Axonal Neuropathy Type 2

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinocerebellar Ataxia With Axonal Neuropathy Type 2 — Drugs in Development & Clinical Trials | BioSniper